logo

For the Inventor, By the Inventor

Shizuoka, Japan

Yoshimasa Oiji

This inventor holds 11 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1981-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimasa Oiji. Retrieved from https://idiyas.com/inventor/yoshimasa-oiji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 69(Granted Patents)


Company Filing History:

goldMedal11 out of 730 
 
Kyowa Hakko Kogyo Co., Ltd.
 patents

Years Active: 1981-1991

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5075301 - Furan derivatives useful for the treatment of gastro-intestinal disorders (1991-12-24),
2. 4851414 - Anti-dementia agent (1989-07-25),
3. 4849441 - Isoindolin-1-one derivative and antiarrhythmic agent (1989-07-18),
4. 4596804 - Dibenz[b,e]oxepin compounds (1986-06-24),
5. 4547496 - Antiulcer [1] benzepino[3,4-b]pyridine and compositions (1985-10-15),
6. 4465835 - Dibenz [b,e] oxepin derivatives (1984-08-14),
7. 4450115 - Amino-alcohol derivatives (1984-05-22),
8. 4396550 - Dibenz [b,e] oxepin derivatives (1983-08-02),
9. 4381398 - Amino-alcohol derivatives (1983-04-26),
10. 4353923 - Pharmaceutical composition containing a benzofurancarboxamide derivative (1982-10-12),
11. 4297369 - Certain muscle relaxant 3-methyl-2-benzofuran acetamides (1981-10-27),

Title: The Innovative Contributions of Yoshimasa Oiji

Introduction

Yoshimasa Oiji is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating gastrointestinal disorders and dementia. With a total of 11 patents to his name, Oiji's work reflects a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest patents, Oiji has developed a furan derivative that is useful for the treatment of gastrointestinal disorders. This compound, along with its pharmaceutically acceptable salt, exhibits gastrointestinal enterokinetic activity, which is expected to be beneficial in a wide range of diseases associated with gastrointestinal dyskinesia. Additionally, he has disclosed anti-dementia agents that comprise an effective amount of a benzylpyridine derivative. This invention pertains to the treatment of dementia through the administration of such anti-dementia agents.

Career Highlights

Oiji is currently associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its innovative approaches in the pharmaceutical industry. His work at the company has allowed him to focus on developing new therapeutic agents that address critical health issues.

Collaborations

Throughout his career, Oiji has collaborated with notable colleagues, including Hiroshi Takizawa and Katsuichi Shuto. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Yoshimasa Oiji's contributions to the field of pharmaceuticals are noteworthy, particularly in the areas of gastrointestinal and dementia treatments. His innovative spirit and dedication to research continue to make a significant impact on medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…